Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
NCT ID: NCT06764706
Last Updated: 2025-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-02-27
2028-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Risankizumab is an approved drug for treating participants with ulcerative colitis. Approximately 200 participants who are prescribed risankizumab by their physician in accordance with local label will be enrolled in approximately multiple sites across Germany and Austria.
Participants will receive risankizumab as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 52 weeks.
There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Risankizumab
Participants will receive risankizumab as prescribed by their physician according to local label.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants initiating risankizumab at the investigator's discretion as part of their routine clinical care; the decision to administer risankizumab must be made prior to and independent of documentation for the study and according to the approved local label.
Exclusion Criteria
* Participants who are currently participating in interventional research (not including noninterventional studies, post-marketing observational study (PMOS), or registry participation).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitaetsklinikum Heidelberg /ID# 275906
Heidelberg, Baden-Wurttemberg, Germany
Klinikum Ernst Von Bergmann /ID# 278268
Potsdam, Brandenburg, Germany
Private Practice - Dr. Kempelmann /ID# 275726
Tostedt, Hamburg, Germany
Gastroenterologische Schwerpunktpraxis /ID# 276701
Hanover, Lower Saxony, Germany
Katholisches Klinikum Bochum gGmbH /ID# 279486
Bochum, North Rhine-Westphalia, Germany
Evangelisches Krankenhaus Kalk /ID# 276414
Cologne, North Rhine-Westphalia, Germany
Dres. Kamp & Partner /ID# 275904
Minden, North Rhine-Westphalia, Germany
Gemeinschaftspraxis Innere Medizin /ID# 280068
Witten, North Rhine-Westphalia, Germany
Gastroenterologische Gemeinschaftspraxis Im Loehr-Center Koblenz /ID# 275943
Koblenz, Rhineland-Palatinate, Germany
Gastroenterologische Schwerpunkt Praxis /ID# 279856
Ludwigshafen am Rhein, Rhineland-Palatinate, Germany
Private Practice - Dr. Johannes Janschek /ID# 275877
Dresden, Saxony, Germany
Universitaetsklinikum Leipzig /ID# 276779
Leipzig, Saxony, Germany
Gesellschaft für klinische Studien /ID# 275867
Leipzig, Saxony, Germany
Private Practice - Dr. Thomas Zeisler /ID# 277933
Halle, Saxony-Anhalt, Germany
Studiengesellschaft BSF Unternehmergesellschaft /ID# 275905
Halle, Saxony-Anhalt, Germany
Praxisgemeinschaft Jerichow Schulze /ID# 275911
Jerichow, Saxony-Anhalt, Germany
Private Practice - Dr. Jaqueline Schumann /ID# 276126
Teuchern, Saxony-Anhalt, Germany
Gemeinschaftspraxis im Medicum /ID# 275933
Altenholz, Schleswig-Holstein, Germany
Praxis S. Tetzlaff /ID# 275882
Buedelsdorf, Schleswig-Holstein, Germany
Praxis Dr. Guenther-Tritsch /ID# 275886
Geesthacht, Schleswig-Holstein, Germany
Private Practice - Dr. Thormann & Dr. Bethge /ID# 275931
Kiel, Schleswig-Holstein, Germany
Praxis fuer Gastroenterologie /ID# 275903
Lübeck, Schleswig-Holstein, Germany
Fek - Friedrich-Ebert-Krankenhaus Neumünster /ID# 276105
Neumünster, Schleswig-Holstein, Germany
Dr. Jack Peter-Stein /ID# 276815
Jena, Thuringia, Germany
Tumorzentrum Nordthuringen Medizinisches Versorgungszentrum /ID# 280072
Nordhausen, Thuringia, Germany
Praxis Heil & Mueller /ID# 275927
Andernach, , Germany
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 275884
Berlin, , Germany
Facharztpraxis fur Gastroenterologie Karlshorst /ID# 277966
Berlin, , Germany
Gastroenterologie im Mühlenbergviertel /ID# 275883
Berlin, , Germany
Dres. Schick/Wesenberg /ID# 275878
Berlin, , Germany
Gastro Studien GbR /ID# 275920
Berlin, , Germany
Drk Kliniken Berlin - Köpenick /ID# 276277
Berlin, , Germany
Private Practice - Dr. Jeannette Schwenzer & Dr. Sven Gruengreiff /ID# 276089
Berlin, , Germany
Praxis Dr. Soellenboehmer /ID# 276183
Berlin, , Germany
Krankenhaus Waldfriede /ID# 275913
Berlin, , Germany
Praxis Dr. Spitz /ID# 275912
Berlin, , Germany
Dres. Bauer/Doerflinger /ID# 276093
Freiburg im Breisgau, , Germany
Private Practice - Dr. Matthias Eichler /ID# 275875
Hamburg, , Germany
Gastroenterologie Rahlstedt /ID# 276408
Hamburg, , Germany
GSGH Gastroenterologische Studiengesellschaft Herne GbR /ID# 275874
Herne, , Germany
Gastroenterologe am Ettlinger Tor /ID# 279854
Karlsruhe, , Germany
Dres. Breitschwerdt/Glas/Gurtler /ID# 276057
Leipzig, , Germany
MVZ Gastroenterologie Leverkusen /ID# 275901
Leverkusen, , Germany
Gastropraxis Magdeburg /ID# 275885
Magdeburg, , Germany
Bettenworth & Partner /ID# 275900
Münster, , Germany
Pc Docs /Id# 275876
Pirmasens, , Germany
Praxis fuer Gastroenterologie /ID# 275946
Schwerin, , Germany
Dres. Rehbehn/Skusa /ID# 276090
Solingen, , Germany
Private Practice - Dr. Markus Braunfels /ID# 277129
Wesseling, , Germany
Dr. Schirin-Sokhan /ID# 276982
Würselen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P25-544
Identifier Type: -
Identifier Source: org_study_id